News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Glenmark Pharmaceuticals, Sanofi (France) in $345 Million Drug-Licensing Pact
May 3, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
WSJ -- India's Glenmark Pharmaceuticals Ltd. said Monday it has agreed to license out development and commercialization rights of a painkiller it is developing to France's Sanofi-Aventis S.A.
Twitter
LinkedIn
Facebook
Email
Print
Alliances
Asia
Sanofi (France)
MORE ON THIS TOPIC
Layoffs
Innate Sheds 30% of Staff, Narrows Pipeline Focus Amid ‘Challenging Funding Environment’
September 17, 2025
·
1 min read
·
Tristan Manalac
FDA
FDA’s Ad Crackdown Targets Novo, Lilly’s Oprah Special on GLP-1s
September 17, 2025
·
3 min read
·
Annalee Armstrong
Manufacturing
GSK Commits $30B To Boost US R&D, Manufacturing Operations
September 17, 2025
·
1 min read
·
Tristan Manalac
Podcast
China Crackdown, UK Exit, Novo Layoffs, Adcomm Flip Flop, More
September 17, 2025
·
2 min read
·
Heather McKenzie
